Stock comparison
Side-by-side financials for BDSX and EXAS. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
EXAS is larger
Market cap data is available for the leading company in this comparison.
Market value leader
EXAS
Latest market capitalization comparison.
Revenue leader
EXAS
BDSX: $88.50M vs EXAS: $3.25B.
Profit leader
BDSX
BDSX: -$35.27M vs EXAS: -$207.95M.
Margin leader
EXAS
BDSX: -39.9% vs EXAS: -6.4% net margin.
| Metric | BDSX | EXAS |
|---|---|---|
| Market cap | - | $20.03 B |
| US-listed rank | - | #623 |
| Revenue (latest FY) | $88.50M | $3.25B |
| Net income (latest FY) | -$35.27M | -$207.95M |
| Net margin | -39.9% | -6.4% |
| P/E (trailing FY) | - | - |
| SEC filings | 586 | 1,834 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, BIODESIX INC reported $88.50M in revenue while EXACT SCIENCES CORP reported $3.25B.
Full pages: BIODESIX INC and EXACT SCIENCES CORP, or browse the full rankings.